Gut Microbiota Stunted Children NTT

Status Completed

Clinical Trial Summary

NTT Province is on the list of priority areas of high prevalence of stunting, Southwest Sumba, South Middle East, and Kupang district have a stunting prevalence of 36.2%, 34.5% and 48.1% respectively in 2020. Therefore, it is necessary to conduct a profile study. microbiota, SCFA, gastrointestinal integrity, parasites, hygiene practice, and cognition in stunting and healthy toddlers in the province of East Nusa Tenggara,

Clinical Trial Description

Stunting indicates a public health problem because it is associated with an increased risk of morbidity and mortality, decreased motor and mental function development, and reduced physical capacity. Stunting is a chronic nutritional deficiency condition that affects the growth and development, and intelligence of children. Lack of nutrients can cause intestinal microbiota dysbiosis where this will reduce the metabolism of short chain fatty acids (SCFA) which will affect the absorption of nutrients in the small intestine and cause impaired immunity, which in turn worsens stunting conditions. The composition of the gut microbiota is influenced by age, sex, geographic area and food intake. Therefore, the description of knowledge, attitudes and applications in society, especially mothers and child subjects, was also analyzed using a hygiene practice questionnaire. The aim of the study was to obtain an overview of the gut microbiota, gastrointestinal integrity, parasitic infections, hygiene practices and cognitive scores in stunting and healthy toddlers in several areas in the province of East Nusa Tenggara as a baseline study to be followed up by intervention study. The research will be conducted for 3 (three) months in 2021/2022. The subjects involved represented 100 stunted children and 100 healthy children aged 36-45 months from each region. Determination of the sample with a sampling quota. The variables studied were the nutritional status of under five years children, characteristics of children under five (age, gender, birth weight (BBL), birth length, breast feeding history, immunization history, history of diarrhea, history of ARI (Upper Respiratory Tract Infection)), mother and family characteristics (age, education). , occupation, father's occupation, total family income), home environment and hygiene, vaccination history, gastrointestinal microbiota status, gastrointestinal integrity, parasites, hygiene practices, and cognitive scores. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05119218
Study type	Observational [Patient Registry]
Source	Bina Nusantara University
Contact
Status	Completed
Phase
Start date	November 2, 2021
Completion date	February 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03268902` - Early Life Interventions for Childhood Growth and Development In Tanzania	Phase 2/Phase 3
Completed	`NCT03683667` - Protein Plus: Improving Infant Growth Through Diet and Enteric Health	Phase 2/Phase 3
Completed	`NCT01562379` - Complementary Food Supplements for Reducing Childhood Undernutrition	Phase 2/Phase 3
Completed	`NCT03819530` - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study	N/A
Completed	`NCT03399617` - SPOON: Sustained Program for Improving Nutrition - Guatemala	N/A
Completed	`NCT05517395` - The Effectiveness of HBM-based Education Program on Improve Knowledge and Behaviors	N/A
Recruiting	`NCT05100550` - Family-based Health Education Program and Zinc Supplementation for Stunted Mother	N/A
Completed	`NCT05120427` - The Impact of Growth Charts and Nutritional Supplements on Child Growth in Zambia	N/A
Recruiting	`NCT06002438` - Eggs for Gut Health	N/A
Active, not recruiting	`NCT02532816` - Nutrient-Dense Complementary Foods on Catch-up Growth and Nutritional Status of Stunting Children	N/A
Completed	`NCT01553552` - Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal	N/A
Recruiting	`NCT05576207` - BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR)	N/A
Active, not recruiting	`NCT04579328` - Impact of Life-size Growth Charts on Understanding of Stunting	N/A
Completed	`NCT03647553` - The Nash-wo-Numa (Childhood Growth & Development) Study
Completed	`NCT03847662` - Scaling up Small-Scale Food Processing to Promote Food Security Among Women Farmers in Rural Vietnam
Completed	`NCT04640389` - Rural-urban Disparities in the Nutritional Status of Younger Adolescents in Tanzania.
Completed	`NCT00970866` - Efficacy of Lipid-Based Nutrient Supplements (LNS) for Pregnant and Lactating Women and Their Infants	N/A
Active, not recruiting	`NCT02441426` - Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development	N/A
Completed	`NCT05322655` - PAthogen Transmission and Health Outcome Models of Enteric Disease
Completed	`NCT03378141` - Maternal Nutrition Interventions in Uttar Pradesh, India	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.